← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2005Last known activity
Dec 31, 2023
Timeline
2000s
- Jun 1, 2002
CardioVascular Research Foundation, Korea— Founded
Drugs by trial phase (16 distinct, 25 trials)
Phase 4 (12 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Angina Pectoris
- Angina Pectoris, Variant
- Angina, Stable
- Aortic Valve Stenosis
- Arteriosclerosis
- Atrial Fibrillation
- Cardiovascular Diseases
- Coronary Artery Disease
- Coronary Disease
- Coronary Stenosis
- Heart Diseases
- Infarction
- Inflammation
- Ischemia
- Kidney Diseases
- Myocardial Infarction
- Myocardial Ischemia
- Plaque, Atherosclerotic
- Syndrome
- Thrombosis
Recent trials (34)
- NCT05672836CollaboratorPhase 4Dec 31, 2023
- NCT05579626Reponsible party - principal investigatorN/ADec 30, 2022
- NCT05579626Lead sponsorN/ADec 30, 2022
- NCT03718559CollaboratorPhase 4May 14, 2019
- NCT03465644CollaboratorPhase 4Oct 15, 2018
- NCT03284827CollaboratorPhase 4Mar 15, 2018
- NCT02790528CollaboratorPhase 4Jul 1, 2017
- NCT02797548CollaboratorPhase 4Mar 16, 2017
- NCT02939872CollaboratorPhase 4Mar 10, 2017
- NCT02494284CollaboratorPhase 4Dec 22, 2015
- NCT02094963CollaboratorPhase 4Jul 5, 2014
- NCT02105623CollaboratorPhase 4Jun 1, 2014
- NCT01905566CollaboratorPhase 4Sep 1, 2013
- NCT01665248Lead sponsorN/AAug 31, 2012
- NCT01665248Sponsor investigatorN/AAug 31, 2012
Details
- Founded
- Seoul, KR Jun 1, 2002
- Last known activity
- Dec 31, 2023